Dejka M. (Steinert) Araujo, M.D.

Peer-Reviewed Articles

1. Christina L. Roland, Elise F. Nassif Haddad, Emily Z. Keung, Wei-Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond S. Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy A. Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F. Lima, Jean-Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, Andrew Futreal, Nadim Ajami, Jennifer A. Wargo, Neeta Somaiah. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature Cancer, 2024.
2. Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys. e-Pub 2023. PMID: 37914142.
3. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2022. PMID: 36151848.
4. Hong DS, Van Tine BA, Biswas S, McAlpine C, Johnson ML, Olszanski AJ, Clarke JM, Araujo D, Blumenschein GR, Kebriaei P, Lin Q, Tipping AJ, Sanderson JP, Wang R, Trivedi T, Annareddy T, Bai J, Rafail S, Sun A, Fernandes L, Navenot JM, Bushman FD, Everett JK, Karadeniz D, Broad R, Isabelle M, Naidoo R, Bath N, Betts G, Wolchinsky Z, Batrakou DG, Van Winkle E, Elefant E, Ghobadi A, Cashen A, Grand'Maison A, McCarthy P, Fracasso PM, Norry E, Williams D, Druta M, Liebner DA, Odunsi K, Butler MO. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat Med 29(1):104-114, 2023. e-Pub 2023. PMID: 36624315.
5. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
6. Gyurdieva A, Zajic S, Chang YF, Houseman EA, Zhong S, Kim J, Nathenson M, Faitg T, Woessner M, Turner DC, Hasan AN, Glod J, Kaplan RN, D'Angelo SP, Araujo DM, Chow WA, Druta M, Demetri GD, Van Tine BA, Grupp SA, Fine GD, Eleftheriadou I. Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma. Nat Commun 13(1):5296, 2022. e-Pub 2022. PMID: 36075914.
7. Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
8. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
9. Patel RR, Lupo PJ, Bishop AJ, Lin PP, Delclos GL, Lazar AJ, Benjamin RS, Araujo DM. Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol 44(7):361-368, 2021. e-Pub 2021. PMID: 33927134.
10. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
11. Pollack SM, Somaiah N, Araujo DM, Druta M, Van Tine BA, Burgess MA, Chawla SP, Seetharam M, Okuno SH, Bohac C, Chen M, Yurasov S, Attia S. Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States. Cancer Med 9(13):4593-4602, 2020. e-Pub 2020. PMID: 32374488.
12. Chow W, Frankel P, Ruel C, Araujo DM, Milhem M, Okuno S, Hartner L, Undevia S, Staddon A. Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma. Cancer 126(1):105-111, 2020. e-Pub 2019. PMID: 31509242.
13. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
14. El Beanino M, Jupiter DC, Assi T, Rassy E, Lazar AJ, Araujo DM, Lin PP. Diagnostic Value of TLE1 in Synovial Sarcoma: A Systemic Review and Meta-Analysis. Sarcoma, 2020.
15. Li J, Chang HM, Banchs J, Araujo DM, Hassan SA, Wagar EA, Yeh ETH, Meng QH. Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin. Cardiooncology 6:1, 2020. e-Pub 2020. PMID: 32154027.
16. El Beaino M, Jupiter DC, Assi T, Rassy E, Lazar AJ, Araujo DM, Lin PP. Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis. Sarcoma 2020:7192347, 2020. e-Pub 2020. PMID: 32322158.
17. Joseph J, Nathenson MJ, Trinh VA, Malik K, Nowell E, Carter K, Weathers SP, Demetri GD, Araujo D, Conley AP. Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor. J Immunother Cancer 7(1):296, 2019. e-Pub 2019. PMID: 31703609.
18. Ramachandran I, Lowther DE, Dryer-Minnerly R, Wang R, Fayngerts S, Nunez D, Betts G, Bath N, Tipping AJ, Melchiori L, Navenot JM, Glod J, Mackall CL, D'Angelo SP, Araujo DM, Chow WA, Demetri GD, Druta M, Van Tine BA, Grupp SA, Abdul Razak AR, Wilky B, Iyengar M, Trivedi T, Winkle EV, Chagin K, Amado R, Binder GK, Basu S. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma. J Immunother Cancer 7(1):276, 2019. e-Pub 2019. PMID: 31651363.
19. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol 42(3):238-242, 2019. e-Pub 2019. PMID: 30614820.
20. Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor The PERSIST-5 Clinical Trial. JAMA Oncol 4(12):e184060, 2018. e-Pub 2018. PMID: 30383140.
21. McBride MJ, Pulice JL, Beird HC, Ingram DR, D'Avino AR, Shern JF, Charville GW, Hornick JL, Nakayama RT, Garcia-Rivera EM, Araujo DM, Wang WL, Tsai JW, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ, Kadoch C. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell 33(6):1128-1141.e7, 2018. e-Pub 2018. PMID: 29861296.
22. Ikoma N, Araujo D, Roland CL. The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste-Reply. JAMA Oncol 3(12):1740, 2017. PMID: 28837712.
23. Furst M, Somogyi MB, Wong RW, Araujo D, Harper CA. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR. Retin Cases Brief Rep. e-Pub 2017. PMID: 29227350.
24. Quintana R, Banchs J, Gupta R, Lin H, Raj S, Conley A, Ravi V, Araujo D, Benjamin RS, Patel S, Vadhan-Raj, S, Somaiah N. Early Evidence of cardiotoxicity and tumor response in patients with sarcomas after high cumulative dose doxorubicin given as a continuous infusion. Sarcoma 2017, 2017.
25. El Beaino M, Araujo DM, Lazar AJ, Lin PP. Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. Ann Surg Oncol 24(8):2145-2154, 2017. e-Pub 2017. PMID: 28397189.
26. Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep 7(1):9519, 2017. e-Pub 2017. PMID: 28842575.
27. Kumar R, Duran C, Amini B, Araujo DM, Wang WL. Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastases: a case report. Skeletal Radiology 46(7), 2017.
28. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. The Oncologist. e-Pub 2017.
29. Vancheswaran Gopalakrishnan, Behrang Amini, Michael J. Wagner, Erica N. Nowell, Alexander J. Lazar, Patrick P. Lin, Robert S. Benjamin, and Dejka M. Araujo. Synovial Sarcoma of the Head and Neck: A Single Institution Review. Sarcoma 2017:1-8, 2017.
30. Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med 12(213):2989-3005, 2016.
31. Gupta R, Heshami N, Jay C, Ramesh N, Song J, Lei X, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Predictors of survival in patients with sarcoma admitted to the intensive care unit. Clinical Sarcoma Research 6(12), 2016.
32. Beaino ME, Araujo DM, Gopalakrishnan V, Lazar AJ, Lin PP. Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons. J Surg Oncol. e-Pub 2016. PMID: 27220538.
33. Lenihan DJ, Stevens PL, Massey M, Plana JC, Araujo DM, Fanale MA, Fayad LE, Fisch MJ, Yeh ET. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. J Card Fail. e-Pub 2016. PMID: 27079675.
34. Fu S, Hou MM, Naing A, Janku F, Hess K, Zinner R, Subbiah V, Hong D, Wheler J, Piha-Paul S, Tsimberidou A, Karp D, Araujo D, Kee B, Hwu P, Wolff R, Kurzrock R, Meric-Bernstam F. Phase I study of Pazopanib and Vorinostat: a Therapeutic Approach for Inhibiting Mutant p53-Mediated Angiogenesis and Facilitating Mutant p53 Degradation. Annals of Oncology 26(5):1012-8, 2015.
35. Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK. Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors. Ann Surg Oncol 21(8):2499-505, 2014. e-Pub 2014. PMID: 24639192.
36. Pappo AS, Vassal G, Crowley JJ, Bolejack V, Hogendoorn PC, Chugh R, Ladanyi M, Grippo JF, Dall G, Staddon AP, Chawla SP, Maki RG, Araujo DM, Geoerger B, Ganjoo K, Marina N, Blay JY, Schuetze SM, Chow WA, Helman LJ. A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Cancer 120(16):2448-56, 2014. e-Pub 2014. PMID: 24797726.
37. Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA, Ross JS, Stephens PJ, Palmer GA, Ali SM. Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein. J Hematol Oncol 14(7(1)):8, 2014. e-Pub 2014. PMID: 24422672.
38. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL, Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma 2014:375151, 2014. e-Pub 2014. PMID: 25024639.
39. Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med 2(4):553-63, 2013. e-Pub 2013. PMID: 24156028.
40. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clinical Sarcoma Research, 2013. e-Pub 2013.
41. Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Soslow RA, Baker LH. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: Results of a phase 2 trial (SARC 005). Cancer 119(8):1555-61, 2013. e-Pub 2013. PMID: 23335221.
42. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Modern Pathology 25(9):1298-306, 2012.
43. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WW, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clinical Sarcoma Research 2(1):2, 2012.
44. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res 2(1):25, 2012. e-Pub 2012. PMID: 23272660.
45. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer, 2011. PMID: 21480200.
46. Yang J, Yang D, Sun Y, Sun B, Wang G, Trent J, Araujo D, Chen K, Zhang W. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer 117(21):4925-38, 2011.
47. Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after defininitive treatment of cutaneous angiosarcoma of the face and scalp. Head Neck 33(5):661-7, 2011.
48. Shinder R, Jackson TL, Araujo D, Prieto VG, Guadagnolo BA, Esmaeli B. Preoperative Radiation Therapy in the Management of Recurrent Orbital Hemangiopericytoma. Ophthal Plast Reconstr Surg, 2011. e-Pub 2011. PMID: 21242853.
49. Pandurengan RK, Dumont AG, Araujo DM, Ludwig JA, Ravi V, Patel S, Garber J, Benjamin RS, Strom SS, Trent JC. Survival of Patients with Multiple Primary Malignancies: A Study of 783 Patients with Gastrointestinal Stromal Tumor. Annals of Oncology 21(10):2107-11, 2010. PMID: 20348145.
50. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig J, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients with Cancer. Annals of Internal Medicine 153(6):358-367, 2010.
51. Jonathan C. Trent, MD, PhD, Shalin S. Patel, Jianhu Zhang, PhD, Dejka Araujo, MD, Juan-Carlos Plana, MD, Daniel J. Lenihan, MD, Dominic Fan, PhD, Shreyaskumar R. Patel, MD, Robert S. Benjamin, MD, and Aarif Y. Khakoo, MD. Rare Incidence of Congestive Heart Failure in Gastrointestinal Stromal Tumor and Other Sarcoma Patients Receiving Imatinib Mesylate. Cancer 116(1):184-192, 2010. PMID: 19885836.
52. Trent JC, Patel SS, Zhang J, Araujo DM, Plana JC, Lenihan DJ, Fan D, Patel SR, Benjamin RS, Khakoo AY. Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate. Cancer 116:184-192, 2010.
53. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Cin PD, Araujo DM, Lev DC, López-Terrada D, Lazar AJ. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol 21(11):1303-10, 2008. PMID: 18587326.
54. Shome D, Trent J, Espandar L, Hatef E, Araujo DM, Song CD, Kim SK, Esmaeli B. Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine. Ophthalmology 115(3):483-7, 2008. PMID: 18201764.
55. Armistead PM, Salganick J, Roh JS, Steinert DM, Patel S, Munsell M, El-Naggar AK, Benjamin RS, Zhang W, Trent JC. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer 110(10):2293-303, 2007. PMID: 17896786.
56. McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 13(22 Pt 1):6727-34, 2007. PMID: 18006774.
57. Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Cancer 107(9):2237-44, 2006. PMID: 16998931.
58. Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate. Cancer 106(7):1617-23, 2006. PMID: 16518826.
59. D'Amato G, Steinert DM, McAuliffe JC, Trent JC. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control 12(1):44-56, 2005. PMID: 15668652.
60. Steinert DM, McAuliffe JC, Trent JC. Imatinib mesylate in the treatment of gastrointestinal stromal tumour. Expert Opin Pharmacother 6(1):105-13, 2005. PMID: 15709888.
61. Prapassorn Thirasastr, Thomas L. Sutton, Cissimol Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P. Conley, John Andrew Livingston, Joseph A Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria Alejandra Zarzour, Elise F Nassif Haddad, Michael S Nakazawa, Xiao Zhou, Michael Heinrich, Neeta Somaiah *. Outcomes in late line systemic treatment in GIST: Does sequence matter?. Cancers.

Invited Articles

1. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR Pathway in Angiosarcoma, Epithelioid Hemangioendothelioma, and Hemangiopericytoma/Solitary Fibrous Tumor. Current Opinion in Oncology 22(4):351-355, 2010.
2. Park MS, Araujo DM. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Current Opinion in Oncology 21(4):327-31, 2009. PMID: 19444101.
3. Steinert DM, Patel SR. Recent studies in novel therapy for metastatic sarcomas. Hematol Oncol Clin North Am 19(3):573-90, viii, 2005. PMID: 15939198.
4. Steinert DM, Blakely LJ, Salganick J, Trent JC. Molecular targets in therapy for human soft-tissue and bone sarcomas. Curr Oncol Rep 5(4):295-303, 2003. PMID: 12781071.

Abstracts

1. Michael Wagner, C. Lunt, D. Araujo, J.-Y. Blay, M. Druta, S. Attia, C.M. Valverde Morales, K. Ganjoo, S. Schuetze, E. Van Winkle, P. Bayer, J. Bai, D. Bestul, V. Desai, M.Yule, D. Williams, E. Norry, B. Van Tine. Health state impacts of Afamitresgene Autoleucel therapy (Afami-cel) in Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: SPEARHEAD-1 Cohort 1 analysis. ESMO Annual Meeting, 2024.
2. Ryan A. Denu, MD, PhD, Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Ravin Ratan, MD, MEd, Maria Alejandra Zarzour, MD, Anthony P. Conley, MD, Dejka Araujo, MD, Vinod Ravi, MD, MS, MBA, Shreyaskumar Patel, MD, Wei-Lien Wang, MD, Alexander J. Lazar, MD, PhD, Neeta Somaiah, MD. Clinico-Genomic Analysis of KIT/PDGFRA/SDH Wild-Type Gatrointestinal Stromal Tumors Identifies Potential Driver Mutations. CTOS Annual Meeting, 2023.
3. Alicia Gingrich, Hannah Beird, Randy Chu, Ray Traweek, Brandon Cope, Emily Z. Keung, Chris P. Scally, Kelly K. Hunt, Keila E. Torres, Christina L. Roland, Sabitha PrabhakaranRare Tumor Initiative Team, Patient Mosaic Team, P. Andrewy Futreal, Andrew Bishop, B. Ashleigh Guadagnolo, Devarati Mitra, Ahsan Farooqi, Dejka Araujo, Alex M. Alejandra Zarzour, J. Andrewy Livingston, Anthony Conley, Shreyaskumar Patel, Vinod Ravi, Neetah Somaiah, Alexander J. Lazar, Ravin Ratan, Elise F Nassif. Leiomyosarcoma intratumoral macrophage infiltrates are associated with distinct clinical and genomic presentations. CTOS Annual Meeting, 2023.
4. Madeline B. Torres, Cheuk Hong Leung, Emily Keung, Chun Feng, Hannah Beird, Alex Zarzour, Chris Scally, Kelly Hunt, Anthony Conley, Andrew Bishop, B. Ashleigh Guadagnolo, Ahsan Farooqi, Devarati Mitra, Dejka Araujo, Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Alex Lazar, Christina L Roland, Neeta Somaiah, Elise F. Nassif. Dedifferentiated Liposarcomas Treated With Immune Checkpoint Blockade: The MD Anderson Experience. CTOS Annual Meeting, 2023.
5. J Andrew Livingston, Jeffrey Cloutier, Anthony P. Conley, Richard Gorlick, Robert S. Benjamin, Kristi Posey, Elise Nassif, M. Alejandra Zarzour, Dejka Araujo, Ravin Ratan, Vinod Ravi, Neeta Somaiah, Heather Lin, Cheuk Hong Leung, Alexander J. Lazar, Valerea O. Lewis, Patrick Lin, Behrang Amini, Raul F. Valenzuela, Shreyaskumar Patel, Wei-Lien Wang. Chemotherapy and Prognostic Significance of Extent of Dedifferentiation in Dedifferentiated Parosteal Osteosarcoma. CTOS Annual Meeting, 2023.
6. Elise F. Nassif, Hannah Beird, Akash Mitra, Bin Liu, Kevin McBride, Wei-Lien Wang, Davis Ingram, Khalida Wani, Emily Z. Keung, Rare Tumor Initiative Team, Patient Mosaic Team, Alex Zarzour, Anthony Conley, Dejka Araujo, J. Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Robert Benjamin, Alexander J. Lazar, Christina L. Roland, P. Andrew Futreal, Neeta Somaiah. Histology Specific Intratumoral B-Cell Biology in Alveolar Soft-Part Sarcomas (ASPS) in Response to Durvalumab-Tremelimumab (D-T). CTOS Annual Meeting, 2023.
7. Lore De Cock, Agnieszka Wozniak, Ming Zhu, Ulla Vanleeuw, Raf Sciot, Guocan Wang, Hannah Beird. Dejka M. Araujo, Patrick Schoffski. Efficacy and Toxicity of Verteporfin in Combination With Pazopanib Tested in a Patient-Derived Synovial Sarcoma Xenograft. CTOS Annual Meeting, 2023.
8. Brian Andrew Van Tine, Kristen N. Ganjoo, Jean-Yves Blay, Claudia Valverde, Dejka M. Araujo, Albiruni Ryan Abdul Razak, Axel Le Cesne, Scott M. Schuetze, Michael J. Wagner, Steven Attia, Edouard Forcade, Mihaela, Seth Pollack, Jane Bai, Paige Bayer, Erin Van Winkle, Elliot Norry, Colin Lunt, Dennis Williams, Sandra P. D'Angelo. Outcomes Of Patients With Advanced Synovial Sarcoma Treated With Afamitresgene Autoleucel ("AFAMI-CEL"). CTOS Annual Meeting, 2023.
9. Riddhi R. Patel, Andrew J. Bishop, Alexander J. Lazar, Patrick P. Lin, Ara A. Vaporciyan, Robert S. Benjamin, Shreyaskumar R. Patel, Joseph A. Ludwig, Vinod Ravi, Dejka M. Araujo. An Institutional Review of Patients Presenting with Localized Primary Intrathoracic Synovial Sarcoma. CPRIT 2023 Innovations IV in Cancer Prevention and Research Conference, 2023.
10. Prapassorn Thirasastr, Heather Y. Lin, Elise F Nassif, Wei-Lien Wang, Dejka M. Araujo, Robert S. Benjamin, Anthony Paul Conley, J Andrew Andrew Livingston, Joseph Aloysius Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria Alejandra Zarzour, Xiao Zhou, Neeta Somaiah. Clinical implications of recurring mutations in myxoid liposarcoma (MLS). ASCO Annual Meeting, 2023.
11. Mirella Nardo, Mohamed Alaa Gouda, Jibran Ahmed, Carmelia Maria Noia Barreto, Blessie Elizabeth Nelson, Dejka M. Araujo, George R. Blumenschein, Apostolia Maria Tsimberidou, Sarina A. Piha-Paul, Ecaterina Elena Dumbrava, David S. Hong. Predictors of survival outcomes in patients (pts) with advanced solid tumors treated with cellular therapies in early clinical trials. ASCO Annual Meeting, 2023.
12. Brian Andrew Van Tine, Kristen N. Ganjoo, Jean-Yves Blay, Claudia Valverde, Dejka M. Araujo, Albiruni Ryan Abdul Razak, Axel Le Cesne, Scott Schuetze, Michael J Wagner, Steven Attia, Edouard Forcade, Mihaela Druta, Seth Pollack, Jane Bai, Paige Bayer, Erin Van Winkle, Elliot Norry, Cheryl McAlpine, Dennis Williams, Sandra P. D'Angelo. The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma. ASCO Annual Meeting, 2023.
13. Dejka M. Araujo, Brian H. Ladle, Kai He, Benjamin Powers, Amanda McGillivray, Ionel Mitrica, Wenlei Liu, Nitin Patel, Sandra P. D'Angelo. ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and myxoid/round cell liposarcoma [Substudy 3, GSK4427296]. ASCO Annual Meeting, 2022.
14. Subramaniam A, Zheng J, Yalamanchili S, Conley AP, Ratan R, Somaiah N, Livingston A, Zarzour MA, Araujo DM, Benjamin RS, Patel S, Ravi V. Modulation of YAP/TAZ by statins to improve survival in epithelioid hemangioendothelioma (EHE). ASCO Annual Meeting, 2020.
15. Somaiah N, Conley AP, Lin HY, Amini B, Sabir SH, Araujo DM, Benjamin RS, Livingston JA, Patel S, Ratan R, Ravi V, Zarzour MA, Wang W-L, Tate T, Roland CL, Daw NC, Futreal A, Lazar AJ, Wistuba II, Hwu P. A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas. ASCO Annual Meeting, 2020.
16. Araujo DM, Druta M, Agulnik M, D'Angelo SP, Blay J-Y, Strauss SJ, Valverde C, Razak ARA, Van Winkle E, Trivedi T, Biswas S, Williams D, Norry E.. SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma. ASCO Annual Meeting, 2020.
17. Raut CP, Espat NJ, Maki RG, Araujo DM, Williams TF, Wolff JE, DeMatteo RP,. PERSIST-5: Five Year Extended Treatment with Adjuvant Imatinib for patients with Intermediate/High Risk Primary Gastrointestinal Stromal Tumor (GIST). J Clin Oncol 35(suppl; abstr 11009), 2017.
18. Mackall C, Tap WD, Glod J, Druta M, Chow WA, Araujo DM, Grupp SA, Van Tine BA, Chagin K, Van Winkle E, Kari G, Trivedi T, Norry E, Holdrich T, Bartlett-Pandite AN, Amado RG, D'Angelo SP. Open Label, Non-Randomized, Multi-Cohort Pilot Study of Genetically Engineered NY-ESO-1c259T in HLA-A2+ Patients with Synovial Sarcoma (NCT01343043). J Clin Oncol 35(suppl; abstr 3000), 2017.
19. Nathenson M, Conley AP, Ratan R, Zarzour MA, Somaiah N, Araujo DM, Patel S, Benjamin RS, Ravi V. Efficacy of front-line chemotherapy for recurrent /metastatic adenosarcoma of the uterus. J Clin Oncol 34(suppl; abstr 11058), 2016.
20. Conley AP, Huh WW, Roszik J, Harrison DJ, Hayes-Jordan AA, Kehr KA, Ratan R, Somaiah N, Ravi R, Araujo DM, Zarzour MA, Ludwig JA, Wang W-L, Benjamin RS, Patel S. Clinical characteristics of adult alveolar rhabdomyosarcoma (ARMS) patients (Pts) on front-line therapies: An MD Anderson Cancer Center (MDACC) series. J Clin Oncol 34(suppl; abstr 11069), 2016.
21. Conley AP, Satcher RL, Wang WL, Lazar AJ, Fox PS, Lin PP Moon B, Bird JE, Araujo DM, Ravi V, Somaiah N, Patel S, Benjamin RS, Lewis VO. Clinical characteristics and treatment outcomes of clear cell chondrosarcoma: MD Anderson Cancer Center Series. J Clin Oncol 33(suppl;abstr 10531), 2015.
22. Vadhan-Raj S, Ravi V, Zhou X, Araujo DM, Somaiah N, Conley AP, Daniel M, Benjamin RS, Patel S, Spasojevic I. Effects of fosaprepitan (FOS) on ifosfamide (Ifex) metabolism in sarcoma patients (pts) receiving multi-day chemotherapy (CT) regimen of doxorubicin (Dox) and Ifex (AI): Randomized, cross-over study. J Clin Oncol 33(suppl; abstr e20714), 2015.
23. Raut CP, Espat J, Maki RG, Araujo DM, Keir CH, Williams TF, DeMatteo RP,. Adjuvant imatinib (IM) for patients (pts) with primary gastrointestinal stromal tumor (GIST) at significant risk of recurrence: PERSIST-5 planned 3-year interim analysis. J Clin Oncol 33(suppl; abstr 10537), 2015.
24. Ravi V, Ramesh N, Patnana M, Conley AP, Somaiah N, Zarzour MA, Ingram D, Little L, Protopopov A, Lazar AJF, Araujo DM, Torres KE, Patel S, Zhang J, Ali SM, Miller VA, Stephens PJ, Benjamin RS, Hwu P, Futreal A. Whole-exome and targeted sequencing of angiosarcomas: Target identification and treatment implications. J Clin Oncol 32(5s):suppl; abstr 10512, 2014.
25. Abouharb S, Warneke CL, Ravi V, Ludwig JA, Lazar AJF, Patel S, Benjamin RS, Araujo DM. Synovial sarcoma: Evaluation of response to treatment with gemcitabine and docetaxel. J Clin Oncol 32(5s):suppl; abstr 10564, 2014.
26. Gupta R, Ramesh N, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Survival and outcomes of critically ill sarcoma patients admitted to the intensive care unit. J Clin Oncol 32(5s):suppl; abstr 10576, 2014.
27. Subbiah V, Agarwal R, Filip J, Tsimberidou AM, Patel S, Benjamin RS, Ludwig JA, Anderson PM, Araujo DM, Ravi V, Conley AP, Somaiah N, Wang WL, Naing A, Zinner R, Hong DS, Meric-Bernstam F. Diversity and heterogeneity in molecular analysis of advanced sarcomas: The clinical, regulatory, and financial challenge for drug development and precision in medicine. J Clin Oncol 32(5s):suppl; abstr 10595, 2014.
28. Somaiah N, Gomes DBD, Madewell JE, Wang WL, Conley AP, Ravi V, Araujo DM, Ludwig JA, Benjamin RS, Patel S. Defining the chemotherapy (CT) response in well-differentiated (WD) and dedifferentiated (DD) liposarcomas (LPS) of the retroperitoneum (RP): A tertiary referral cancer center experience. J Clin Oncol 32(5s):suppl; abstr 10583, 2014.
29. Williams LA, Araujo DM, Quiling S, Ali NN, Ahaneku H, Jing K, Trent JC, Cleeland CS. Symptoms in gastrointestinal stromal tumors. J Clin Oncol 32(5s):suppl; abstr 9637, 2014.
30. Vadhan-Raj S, Zhou X, Araujo DM, Somaiah N, Conley AP, Ravi V, Daniel M, Benjamin RS, Patel S. Effects of fosaprepitant (Fosa) administered as single dose versus two doses, on nausea/vomiting (N/V) in patients receiving multiday chemotherapy (CT) with a highly emetogenic regimen of doxorubicin and ifosfamide (AI): Randomized cross-over study. J Clin Oncol 32(5s):suppl; abstr 9616, 2014.
31. Trent JC, Salganick JA, Thall PF, Patel SR, Araujo DM, Benjamin RS. Efficacy and safety of low-dose protracted irinotecan in patients with advanced sarcomas: results from a phase II study. CTOS Annual Meeting - Oral Presentation:90, 2011.
32. Hensley ML, Wathen K, Maki RG, Araujo DM, Sutton GP, Priebat DA, George S, Baker LH. 3-year follow-up of SARC005: Adjuvant treatment og high risk primary uterine leiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D). CTOS Annual Meeting(Poster #78):38, 2011.
33. Demicco E, Park M, Araujo D, Bassett R, Lazar AJ, Wang WL,. Solitary fibrous tumor/hemangiopericytoma: clinicopathologic predictors of outcome. CTOS Annual Meeting(Poster # 205):55, 2011.
34. Gao J, McAuliffe JC, Lazar AJF, Wang W, Choi H, Hunt K, Araujo DM, Pollock RE, Benjamin RS, Trent JC.. Mechanism of early radiographic response to imatinib in GIST. ASCO Annual Meeting, 2011.
35. Dumont SN, Trent JC, Patel S, Araujo DM, Dumont AG, Benjamin RS. A phase II study of low-dose protracted irinotecan in patients with advanced sarcomas. ASCO Annual Meeting, 2011.
36. Ravi V, Yang J, Araujo DM, Park MS, Benjamin RS, Zhang W, Trent JC, Patel S. The role of E-cadherin expression in response and outcome in patients with leiomyosarcoma treated with chemotherapy. ASCO Annual Meeting, 2011.
37. Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, Lev D, Wang X, Benjamin RS, Araujo DM. The role of chemotherapy in advanced hemangiopericyoma/solitary fibrous tumor. ASCO Annual Meeting, 2011.
38. Park MS, Patel SR, Trent JC, Wang WL, Conley AP, Benjamin RS, Araujo DM. Multidisciplinary management of patients with primary pulmonary artery sarcoma (PPAS). CTOS Annual Meeting, 2010.
39. Dumont SN, Araujo DM, Dumont AG, Conley AP, Reynoso DG, Raymond K, Munsel MF, Patel S, Benjamin RS, Trent JC. Adult Rhabdomyosarcoma: 239 Patients Followed at MD Anderson Cancer Center. CTOS Annual Meeting - Oral Presentation, 2010.
40. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lewis VO, Lin P, Pollock RE, Guadagnolo A, Zagars G, Benjamin RS, Madewell JE, Lazar AJ. Extensive fatty maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosamide and pre-operative radiation therapy. CTOS Annual Meeting, 2010.
41. Ravi V, Wang W, Araujo DM, Ludwig JA, Luke RJ, Lewis VO, Trent JC, Benjamin RS, Patel S. Imatinib in the Treatment of Tenosynovial Giant-Cell Tumor and Pigmented Villonodular Synovitis. ASCO Annual Meeting, 2010.
42. Park MS, Patel S, Trent JC, Wang W, Conley AP, Benjamin RS, Araujo DM. Multidisciplinary Management of Patients with Primary Pulmonary Artery Sarcoma (PPAS). ASCO Annual Meeting, 2010.
43. Katz D, Boonsirikamchai P, Benjamin RS, Patel S, Ludwig JA, Trent JC, Xiao L, Ravi V, Choi H, Araujo DM. Efficacy of Neoadjuvant Doxorubicin and Ifosfamide (AI) in Myxoid/Round Cell Liposarcoma (MRCL): The M.D. Anderson Cancer Center Experience (MDACC). ASCO Annual Meeting, 2010.
44. Hensley ML, Wathen K, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Baker LH,. Adjuvant Treatment of High-Risk Primary Uterine Leiomyosarcoma with Gemcitabine/Docetaxel (GT), Followed by Doxorubicin (D): Results of Phase II Multicenter Trial SARC005. ASCO Annual Meeting, 2010.
45. S. Vadhan-Raj, J. Trent, D.M. Araujo, S. Patel, X. Zhou, R.S. Benjamin. Evaluation of AMG 531 in chemotherapy-induced thrombocytopenia (CIT): Results of a phase I/II study. ASCO Annual Meeting, 2009.
46. A.P. Conley, D. Araujo, J. Ludwig, V. Ravi, B.L. Samuels, H. Choi, P.F. Thall, S. Patel, R. Benjamin, J. Trent,. A randomized phase II study of perifosine (P) plus imatinib for patients with imatinib-resistant gastrointestinal stromal tumor (GIST). ASCO Annual Meeting, 2009.
47. Park MS, Lazar AJ, Trent JC, Conrad CA, Ludwig JA, Wang WL, Boonsirikamachi P, Choi H, Patel SR, Benjamin RS, Araujo DM.. Combination therapy with temozolamide and bevacizumab (TMS/BV) in he treatment of hemangiopericytoma/solitary fibrous tumor (HPC/SFT): An updated analysis. CTOS Annual Meeting - Oral Presentation, 2008.
48. Vadhan-Raj S, Trent JC, Patel SR, Araujo DM, Ludwig JA, Bailey D, Zhou X, Gillenwater A, El-Naggar A, Benjamin RS. Randomized, double-blind, placebo-controlled study of palifermin for the prevention of mucositis in patients receiving doxorubicin-based chemotherapy. ASCO Annual Meeting, 2008.
49. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Choi H, Benjamin RS, Araujo DM. Combination therapy with temozolamide and bevacizumab in the treatment of hemangiopericytoma/malignant solitary fibrous tumor. ASCO Annual Meeting, 2008.
50. Steinert D, Henderson C, Chawla S, Staddon A, Schuetze S, Ryan C. A phase II trial of perifosine in patients with chemoinsensitive sarcomas: Preliminary results A Sarcoma for Reseach through Collaboration (SARC) Study. CTOS Annual Meeting, 2007.
51. McAuliffe JC, Lazar A, Steinert D, Patel S, Benjamin R, Trent. Kit-stem cell factor (kit ligand) axis in GIST treated with imatinib. ASCO Annual Meeting, 2007.
52. Lenihan DJ, Massey MR, Baysinger K, Steinert D, Fayad L, Yusuf SW, Chiu A, Durand J, Yeh ET. Early detection of cardiotoxicity during chemotherapy using biomarkers. ASCO Annual Meeting, 2007. e-Pub 2007.
53. Khakoo AY, Steinert DM, Patel SR, Plana JC, Ludwig J, Benjamin RS, Trent JC. Rare incidence of congestive heart failure (CHF) in gastrointestinal stromal tumors (GIST) and other sarcoma patients (pts) receiving imatinib mesylate (IM) therapy. ASCO Annual Meeting, 2007.
54. Steinert DM, Salganick J, Ballo M, Zhang W, Munsell M, Raney B, Jaffe N, Koh J, El-Naggar A, Trent J. Expression of Bax and Bcl-2 in human rhabdomyosarcoma: Correlation with survival in 64 patients. ASCO Annual Meeting, 2005.
55. Steinert DM, Trent JC, Blakely LJ, Patel SR, Burgess MA, Chen LL, Raymond AK, Benjamin RS. Outcomes of gastrointestinal stromal tumors (GIST) and other intra-abdominal sarcomas (IAS) in the era of imatinib therapy. ASCO Annual Meeting, 2004.

Book Chapters

1. Steinert DM, Trent JC:. Gastrointestinal stromal tumors. In: Ajani JA, Curley SA, Janjan NA, Lynch PM Gastrointestinal Cancer. M.D. Anderson Cancer Care Series. Springer Science + Business Media, Inc: New York, 2005.